Barely Significant
← all excerpts

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone.

Br J Cancer · 2015 · PMC4815793 · PMID 26461062

Europe PMCDOI
1
hedged sentence
0.0490
closest p · 1.0× alpha
0.0490
boldest claim

The sentences

weakly significantP =0.049actually significant
Overall, a higher rate of pR was obtained when the anti-EGFR was combined with an irinotecan vs an oxaliplatin chemotherapy backbone, but difference was weakly significant (72% vs 53% P =0.049).

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.